Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $630.
January 23, 2024 | 4:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirms an Overweight rating on Eli Lilly with a steady price target of $630.
The reiteration of an Overweight rating and a high price target by a reputable analyst like Louise Chen could lead to increased investor confidence in Eli Lilly, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100